Skip to main content
ELV
NYSE Life Sciences

Elevance Health 重申 FY2026 每股收益指导不低于 $25.50，包括 CMS 制裁影响

feedReported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$281.84
Mkt Cap
$61.961B
52W Low
$273.71
52W High
$458.75
Market data snapshot near publication time

summarizeSummary

Elevance Health 重申了其调整后股东收益指导，为 2026 财年每股摊薄收益至少为 $25.50。这一声明具有重要意义，公司明确表示，该指导已经考虑了 Medicare 和 Medicaid 服务中心 (CMS) 制裁的潜在影响，这些制裁于 3 月 2 日宣布，涉及暂停新 Medicare Advantage 注册。这为投资者提供了关键的明确性，表明管理层认为制裁的财务影响在其现有预期内是可控的，可能不需要下调其全年指导。交易者可能将此视为稳定因素，可能限制了最近有关 CMS 制裁的负面新闻之后的进一步下跌。

在该公告发布时，ELV的交易价格为$281.84，交易所为NYSE，所属行业为Life Sciences，市值约为$619.6亿。 52周交易区间为$273.71至$458.75。 这则新闻被评估为中性市场情绪，重要性评分为7/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed ELV - Latest Insights

ELV
Apr 22, 2026, 10:09 AM EDT
Filing Type: 10-Q
Importance Score:
8
Elevance Health Reports Q1 GAAP EPS Decline and $935M Regulatory Accrual
Sentiment: Negative
View Wiseek Article
ELV
Apr 22, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Elevance Health Beats Q1 EPS, Raises Full-Year Guidance Despite $935M CMS Accrual
Sentiment: Positive
View Wiseek Article
ELV
Apr 22, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
8
Elevance Health Beats Q1 Adjusted EPS by $1.78, Boosts Full-Year Guidance
Sentiment: Positive
View Wiseek Article
ELV
Mar 10, 2026, 6:10 AM EDT
Source: Reuters
Importance Score:
7
Elevance Health Reaffirms FY2026 EPS Guidance of At Least $25.50, Including CMS Sanctions Impact
Sentiment: Neutral
View Wiseek Article
ELV
Mar 10, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Elevance Health Reaffirms 2026 Earnings Guidance Despite Medicare Sanctions
Sentiment: Neutral
View Wiseek Article
ELV
Mar 02, 2026, 6:13 AM EST
Source: Unknown
Importance Score:
8
CMS Threatens to Suspend Elevance Health's MA-PD Enrollment Over Risk-Adjustment Issues
Sentiment: Negative
View Wiseek Article
ELV
Mar 02, 2026, 6:03 AM EST
Filing Type: 8-K
Importance Score:
8
CMS Imposes Sanctions on Elevance Health, Suspending Medicare Advantage Enrollment
Sentiment: Negative
View Wiseek Article
ELV
Feb 26, 2026, 2:59 PM EST
Filing Type: 8-K
Importance Score:
7
Elevance Health Announces Executive Leadership Changes, Reaffirms FY26 Guidance
Sentiment: Neutral
View Wiseek Article
ELV
Feb 06, 2026, 2:57 PM EST
Filing Type: 10-K
Importance Score:
7
Elevance Health Reports Mixed FY25 Results with Profit Decline and Significant Regulatory Headwinds
Sentiment: Negative
View Wiseek Article
ELV
Jan 28, 2026, 6:03 AM EST
Filing Type: 8-K
Importance Score:
8
Elevance Health Reports Q4 & FY25 Results; Issues Significantly Lower FY26 EPS & Revenue Guidance
Sentiment: Negative
View Wiseek Article